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Bidirectional ventricular tachycardia (BVT) is a rare variety of tachycardia with morpho-
logically distinct presentation: The QRS axis and/or morphology is alternating in the frontal
plane leads. Since its original description in association with digitalis,1 numerous cases of
this fascinating tachycardia with disparate etiologies and mechanisms have been postu-
lated. We report a patient with BVT in association with non-ST elevation myocardial
infarction and severe cardiomyopathy in the absence of digoxin toxicity.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Case report
A 61-year-old African American male with history of
myocardial infarction in the remote past came to the emer-
gency department with chest pressure associated with
nausea, vomiting, palpitation and diaphoresis for two days,pital, 2200 Philadelphia D
A.-M. Masood).
ciety of India. All rightswhich became progressively worse. On a 12-lead EKG he had
sustained monomorphic ventricular tachycardia at a rate of
153 beats per minute at the time of presentation to the ED
(Figs. 1 and 2). After initial doses of amiodarone and lidocaine
failed to restore sinus rhythm, he was cardioverted by trans-
thoracic approach with 100 J synchronized, biphasic direct
current shock. Initially intravenous abciximab drip startedr. Suite 441, Dayton, OH 45406, USA. Tel.: þ1 937 734 4690, þ1 630
reserved.
Fig. 1 e Accelerated idio-ventricular rhythm, 3rd complex is sinus with aberrant conduction, 5th beat is a PVC and
subsequent blocked PAC.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 6 6e4 6 9 467based on high suspicion of STEMI, which was later dis-
continued and patient was continued on heparin and amio-
darone drips.
He had a history of ischemic cardiomyopathy, hyperten-
sion, COPD, hyperlipidemia and chronic renal insufficiency.
His left ventricular ejection fraction was 20%. He was taking
Fenofibrate 48 mg per day, Altace 10 mg per day,Fig. 2 e Sustained monomorphHydrochlorthiazide 25 mg per day and Furosemide 40 mg
twice a day. He was not on any beta-blockers.
Patient was alert and oriented to time place and person
during presentation followed by loss of consciousness. His
blood pressure was 84/62, heart rate 153, respiratory rate 18.
He had S3 gallop and diminished breath sounds with minimal
rales bilaterally.ic ventricular tachycardia.
Fig. 3 e Bidirectional ventricular tachycardia.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 6 6e4 6 9468Abdomen was distended and he had 2þ pitting edema. His
initial laboratory data revealed: blood urea nitrogen 41 mg/dl,
creatinine 3.5 mg/dl, CPK 110 units/l, CKMB 5.8 ng/ml,
Troponin-I 1.6 ng/ml, BNP 748 pg/ml. Electrolytes were
normal. A 2-D Echocardiogram revealed dilated cardiomyop-
athy, mild septal hypertrophy in the outflow tract, LVEF 10%,
moderate to severe mitral regurgitation and tricuspid
regurgitation.
An urgent coronary angiography showed completely
occluded right coronary artery disease with mild diffuse dis-
ease in other coronary system. Right atrial pressure of 26 and
left ventricular end-diastolic pressure of 48 mm of Hg.
On the 3rd hospital day, patient developed bidirectional
ventricular tachycardia (Fig. 3). He was given additional bolus
of amiodarone with resolution of VT (Fig. 4).2. Discussion
Causes of bidirectional ventricular tachycardia:Acute ischemia
Aconitine poisoning
Catecholaminergic Polymorphic VT
Digoxin Toxicity
Familial Hypokalemic Periodic Paralysis
Fatty replacement in RV
Tumor of the Ventricle
Myocarditis2.1. Ischemic heart disease
Mechanism of ventricular tachycardia is complex in the
setting of acute coronary syndrome and it is mediated due to
interaction of ionic imbalances with neurohumoral changes
togetherwith increase in electrical resistance between cardiac
myocytes. During ischemia, there is net loss of Kþ in the
extracellular space which is compensated by net intracellularFig. 4 e Abrupt termination ofNaþ gain through various major Na influx pathways. Intra-
cellular Naþ results in increase in Caþ influx via Caþ/Naþ
exchanger. The net increase in Caþ may increase delayed
after-depolarization (DAD) related arrhythmia including BVT.
BVT is rare in the setting of acute myocardial infarction
and very few case reports are described in the literature. A
case of BVTwas reported in associationwith acutemyocardial
infarction and aortic stenosis.2 Another case report is in a
patient with myocardial infarction.3 Our case is the fourth
case report to our knowledge.
In a canine model of ischemia,4 where LAD was ligated to
produce ischemic zone, reentrant bidirectional PVC's were
inducible on pacing. If these bidirectional PVC's continued to
perpetuate, they would appear as sustained BVT which was
occasionally observed during these experiments.42.2. Catecholaminergic polymorphic ventricular
tachycardia (CPVT)
Majority of patients with CPVT may present as BVT.5 It is
associated with channelopathy6 and has been linked to a
variant of long QT syndrome. Typically it is a familial7 form of
catecholamine mediated, exercise induced, bidirectional
tachycardia with an autosomal dominant pattern of inheri-
tance. An early age of onset and mortality as high as 30% by
the age of 30 years has recently been described.8
In a normal cardiac cell, depolarization of the membrane
initiates calcium influx via voltage dependent L type Ca2þ
channel. This calcium in turn causes calcium-induced cal-
cium release from ryanodine receptor 2 (RyR2), which in turn
is responsible for activation of actin-myosin molecules lead-
ing to contraction of the heart muscles. During diastole, cal-
cium enters back into the SR, via the RyR2 receptor.
In patientswith CPVT due to a defect in RyR28,9 the channel
remains open for longer duration time, extending into dias-
tole, increasing the calcium release from SR into the cell.
Some of this Ca2þ is exchanged via the Naþ/Ca2þ exchangerbidirectional tachycardia.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 6 6e4 6 9 469(NCX). The net increase in transient inward current leads to
delayed after-depolarization (DAD) depolarization in Phase IV
of monophasic action potential triggering polymorphic
or BVT.
2.3. Digoxin toxicity
In normal heart Na/K ATP-ase pump is responsible for
extrusion of three molecules of sodium in exchange for 2
molecules of potassium. Digoxin binds the Na/K ATP-ase
pump resulting in net increase in Nai. The excess Nai in the
cytoplasm is exchanged with Cao
2þ via Naþ-Ca2þ exchanger in
1:3 proportion. Only a small amount of Cai is a trigger for a
sudden and large flow of calcium from the sarcoplasmic re-
ticulum into the cytoplasm. Actin-myosin chains interact,
resulting in enhanced contractility in patients with heart
failure.
Digoxin also facilitates opening state of the RyR2 receptor
increasing the rate and flow of calcium into the cytoplasm.
This sudden release of calcium current is responsible for the
positive inotropic effects of digoxin on cardiomyocyte and is
also responsible for phase 4 DAD. If the amplitude of this DAD
is sufficiently large, it triggers a polymorphic or BVT. Digoxin
associated bidirectional ventricular tachycardia was first re-
ported in 1922.1
2.4. Carvedilol and its effect on ryanidine receptor
Recent data suggest that Carvedilol has a specific RYR receptor
blocking effect, hence the drug prevents sudden and large
surges of Ca release from the sarcoplasma reticulum. Carve-
dilol's superiority to metoprolol among HF patients as
demonstrated in MERIT-HF trial could have been due to the
RYR receptor blocking effect. Based on this assumption, Car-
vedilol may be a superior agent in the treatment of CPVT
where the surge of Ca release is due to genetic defect, which
accelerates the release of calcium mediated calcium release
from SR via RYR receptor.3. Conclusion
1 BVT is a rare variety of VT, which is generally seen with
digoxin toxicity or catecholaminergic PMVT both of which
are associated with one common denominator-
intracellular calcium overload. Rarely patients may have
BVT due to anatomic causes such as due to fattyreplacement in RV (not to be confused with arrhythmo-
genic RV dysplasia) or tumor of the heart. Rarely, it has
been reported in association with acute myocardial
infarction. We described a case of BVT in association with
acute MI which was managed medically. EP study was not
done. Treatment of ischemia was given priority in this
patient as ablation therapy has limited role in this disorder.
Treatment has to be individualized and therapy with beta-
blocker the cornerstone of treatment. However, surgical
approach may be needed in the anatomic variety of BVT.Conflicts of interest
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